A new study shows that blood collected on a sanitary pad can be used for cervical cancer screening, opening the door to new diagnostics ...

Women who get a full dose of the human papillomavirus (HPV) vaccine may only need two cervical cancer screenings in their ...

Maybe in Norway but probably not in the U.S., expert says ...

Every day almost 2,000 women around the world sit down opposite a doctor and are told they have cervical cancer.

In the U.S., lower HPV vaccination rates, uneven access to screening and delayed adoption of HPV-based testing have contributed to preventable illness and death. These are not inevitable outcomes; ...

Menstrual blood HPV testing may offer a non-invasive option for cervical cancer screening with strong diagnostic accuracy. Learn more about the study.

Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...

About 70 per cent of cases are prevented through cervical screening, according to cancer research, and the HPV vaccine is ...

A modeling study of Norway, which has high HPV vaccination coverage and uniform cervical cancer screening, suggests fewer ...

A recent study out of Norway suggests that female who have received the HPV vaccine may be able to have fewer cervical cancer ...

The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...

Feb 6 (Reuters) - Women vaccinated against the human papillomavirus can safely skip many of the cervical cancer screenings that are typically recommended every three to five years, a new study from ...